Xyntha

BIOLOGICAL3 trials

Sponsors

Pfizer, Sinocelltech Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Conditions

Hemophilia A

Phase 1

Pharmacokinetic Study of SCT800 in Previously Treated Patients With Hemophilia A

Sinocelltech Ltd.Hemophilia A

Start: 2016-09-30End: 2017-07-31Target: 16Updated: 2016-09-02

Pharmacokinetics Evaluation of Recombinant Coagulation Factor VIII Injection in Subjects With Hemophilia A.

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Hemophilia A

Start: 2019-05-08End: 2020-03-31Target: 24Updated: 2019-08-19

Phase 3

Study Evaluating On-Demand Treatment Of Xyntha In Chinese Subjects

CompletedNCT00868530

PfizerHemophilia A

Start: 2008-09-30End: 2009-12-31Updated: 2025-06-12

Related Papers

Safety and Efficacy of Moroctocog Alfa (AF-CC) in Chinese Patients with Hemophilia A: Results of Two Open-Label Studies.

2020-11-253 citations